For citations:
Aleksandrov T.L., Vykova B.A., lgnatenko M.A., Belous S.S., Sergeeva K.A., Korgunova M.V. Survival of infliximab and adalimumab biosimilar therapy in patients with Crohn's disease. Koloproktologia. 2025;24(2):22-32. https://doi.org/10.33878/2073-7556-2025-24-2-22-32